SecSonar.com

Fractyl Health, Inc. Common Stock (GUTS)

Fractyl Health, Inc. Common Stock at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Fractyl Health, Inc. Common Stock (GUTS) is a Biotechnology company based in US with a market capitalization of $58.9M. Free cash flow was negative at -$90.9M. This page tracks GUTS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 107 employees · IPO Feb 2, 2024

Valuation

Valuation & price

$0.86 · as of May 17, 2026 · -63.7% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

6.23

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.37$1.39$0.42Jul 25Dec 25Jul 26Jul 7, 25$1.54Jul 9, 25$1.53Jul 11, 25$1.52Jul 15, 25$1.49Jul 17, 25$1.79Jul 21, 25$1.80Jul 23, 25$1.92Jul 25, 25$1.92Jul 29, 25$1.82Jul 31, 25$1.84Aug 4, 25$1.86Aug 6, 25$1.01Aug 11, 25$0.98Aug 13, 25$1.01Aug 15, 25$1.02Aug 19, 25$0.99Aug 21, 25$0.99Aug 25, 25$1.00Aug 27, 25$0.99Aug 29, 25$0.97Sep 3, 25$0.93Sep 5, 25$0.92Sep 9, 25$0.97Sep 11, 25$1.02Sep 16, 25$0.99Sep 18, 25$0.99Sep 22, 25$0.99Sep 24, 25$0.99Sep 26, 25$1.34Sep 30, 25$1.59Oct 2, 25$1.57Oct 6, 25$1.47Oct 8, 25$1.40Oct 10, 25$1.34Oct 14, 25$1.35Oct 16, 25$1.27Oct 21, 25$1.34Oct 23, 25$1.38Oct 27, 25$1.30Oct 29, 25$1.25Oct 31, 25$1.23Nov 4, 25$1.12Nov 6, 25$1.09Nov 10, 25$1.12Nov 12, 25$1.13Nov 14, 25$1.26Nov 18, 25$1.40Nov 20, 25$1.29Nov 25, 25$1.46Nov 28, 25$1.57Dec 2, 25$1.84Dec 4, 25$1.98Dec 8, 25$2.23Dec 10, 25$2.34Dec 12, 25$2.24Dec 16, 25$2.16Dec 18, 25$2.26Dec 22, 25$2.28Dec 24, 25$2.25Dec 29, 25$2.37Jan 2, 26$2.25Jan 6, 26$2.00Jan 8, 26$2.10Jan 12, 26$2.00Jan 14, 26$2.01Jan 16, 26$1.91Jan 21, 26$1.85Jan 23, 26$2.09Jan 27, 26$2.12Jan 29, 26$0.58Feb 2, 26$0.47Feb 4, 26$0.43Feb 9, 26$0.43Feb 11, 26$0.43Feb 13, 26$0.42Feb 18, 26$0.42Feb 20, 26$0.47Feb 24, 26$0.48Feb 26, 26$0.47Mar 2, 26$0.50Mar 4, 26$0.50Mar 6, 26$0.48Mar 10, 26$0.49Mar 12, 26$0.47Mar 17, 26$0.46Mar 19, 26$0.44Mar 23, 26$0.45Mar 25, 26$0.50Mar 27, 26$0.45Mar 31, 26$0.46Apr 2, 26$0.46Apr 7, 26$0.45Apr 9, 26$0.47Apr 13, 26$0.49Apr 15, 26$0.54Apr 17, 26$0.57Apr 22, 26$0.59Apr 24, 26$0.62Apr 28, 26$0.66Apr 30, 26$0.64May 4, 26$0.73May 6, 26$0.74May 8, 26$0.75May 12, 26$0.73May 14, 26$0.95May 18, 26$0.81May 20, 26$0.92May 22, 26$0.91May 28, 26$0.84Jun 1, 26$0.87Jun 3, 26$0.76Jun 5, 26$0.68Jun 9, 26$0.66Jun 11, 26$0.72Jun 15, 26$0.85Jun 17, 26$0.85Jun 22, 26$0.87Jun 24, 26$0.78Jun 26, 26$0.74Jul 2, 26$0.76
$0.3952-week range$2.37
Loading valuation history…

Fundamentals

Key fundamentals

$58.9M

Market cap

—

Revenue growth (YoY)

46.2%

Gross margin

-$90.9M

Free cash flow (USD)

-$19.9M

Net debt

Net cash position

74.1%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$0.00FY 2020$0.00FY 2021$0.00FY 2022$0.00FY 2023$120.0KFY 2024$93.0KFY 2025$0.00
$0$0

Free cash flow by year

2019 → 2025

FY 2019$-27.8MFY 2020$-31.1MFY 2021$-33.5MFY 2022$-46.3MFY 2023$-43.2MFY 2024$-67.3MFY 2025$-90.9M
-$27.8M-$90.9M

Gross margin by year

2023 → 2024

FY 202335.8%FY 202446.2%
35.8%46.2%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

4

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 12, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider buyInsider Buy $20KRoyan Ajay · Director · $19.6KJun 15, 2026Filing
  • Insider buyInsider Buy $26KSheffield Ian · Director · $25.5KJun 11, 2026Filing
  • Insider buyInsider Buy $50KBRADLEY WILLIAM · Director · $50.3KJun 11, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 11, 2026Filing
  • Insider buyInsider Buy $14KSmith Weber Lara · Chief Financial Officer · $13.7KJun 9, 2026Filing
  • 8-K eventPositive Clinical ResultsJun 4, 2026Filing
  • 8-K eventEarnings ReleaseMay 12, 2026Filing
  • Quarterly report10-Q FiledMay 12, 2026Filing
  • 8-K eventClinical Trial AuthorizationMay 11, 2026Filing

Questions

Frequently asked questions

What is Fractyl Health, Inc. Common Stock's market cap?

Fractyl Health, Inc. Common Stock (GUTS) has a market capitalization of $58.9M.

What is GUTS's P/E ratio?

A meaningful P/E ratio is not available for GUTS — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is GUTS's price-to-book (P/B) ratio?

GUTS trades at 6.23 times book value per share.

Are insiders buying GUTS stock?

Yes — SEC Form 4 filings show 4 open-market insider buys and 0 sells at Fractyl Health, Inc. Common Stock in the last 90 days.

Same arena

Related companies in Biotechnology

CUE

Cue Biopharma, Inc.

$57.5M

ENTX

Entera Bio Ltd.

$62.3M

MREO

Mereo BioPharma Group plc

$55.5M

RANI

Rani Therapeutics Holdings, Inc.

$63.5M

ATYR

aTyr Pharma, Inc.

$53.9M

VRCA

Verrica Pharmaceuticals Inc.

$64.1M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.